
Elpis Biopharma signs MoU with NCCS to conduct translational cell therapy research in Singapore
Elpis Biopharma signs MoU with NCCS to conduct translational cell therapy research in Singapore July 28, 2025 | Monday | News Accelerating the delivery of potential groundbreaking new cancer therapies to patients in Singapore US-based startup Elpis …